NASDAQ Biotechnology Total Retu XNBI Indice
4695.64 USD
{{ price }}
1.629337%
{{change_pct}}%
PAYS
États-Unis
Marché
Nasdaq GIDS
Plus Haut - Plus Bas [24H]
4609.5
-
4708.74 USD
Nombre de composants
190
NASDAQ Biotechnology Total Retu Graphique des prix
Top 5 Gagnants au Cours des Dernières 24 Heures
| PACB | Pacific Biosciences of California | +15.5% | |
|---|---|---|---|
| ESPR | Esperion Therapeutics | +15% | |
| MGNX | MacroGenics | +9.52% | |
| IONS | Ionis Pharmaceuticals | +9.14% | |
| RARE | Ultragenyx Pharmaceutical | +8.83% |
Top 5 Perdants au Cours des Dernières 24 Heures
| EGRX | Eagle Pharmaceuticals | -18.62% | |
|---|---|---|---|
| CRIS | Curis | -18.6% | |
| TRVN | Trevena | -17.27% | |
| INVA | Innoviva | -1.97% | |
| DBVT | DBV | -1.81% |
NASDAQ Biotechnology Total Retu XNBI APERÇU FINANCIER ET COMMERCIAL
| NASDAQ Biotechnology Total Retu Prix de l'Indice | 4695.64 USD |
| Dernière clôture | 4472.96 USD |
| Ouverture | 4476.26 USD |
| Offre | 0 USD x 0 |
| Demande | 0 USD x 0 |
| Variation du jour | 4464.53 - 4532.84 USD |
| Plage sur 52 semaines | 4464.53 - 4532.84 USD |
| Volume | 0 USD |
| Volume moyen | N/A |
Informations de trading
NASDAQ Biotechnology Total Retu Historique des prix de l'Indice
| Plus haut sur 52 semaines | 4532.84 USD |
| Plus bas sur 52 semaines | 4464.53 USD |
| Moyenne mobile sur 50 jours | N/A |
| Moyenne mobile sur 200 jours | N/A |
XNBI Statistiques de l'indice
| Volume moyen (3 mois) | N/A |
| Volume journalier moyen (10 jours) | N/A |
Questions et réponses concernant l'indice NASDAQ Biotechnology Total Retu
Quel est le cours actuel de l'Indice XNBI ?
Le prix de l'Indice NASDAQ Biotechnology Total Retu XNBI aujourd'hui est de 4695.64 USD.
Comment acheter l'Indice NASDAQ Biotechnology Total Retu ?
Vous pouvez acheter l'indice XNBI sur la plateforme Nasdaq GIDS. Contactez votre conseiller financier pour choisir un courtier.
Quel est le symbole boursier de l'Indice NASDAQ Biotechnology Total Retu ?
Le symbole boursier ou ticker de l'Indice NASDAQ Biotechnology Total Retu est XNBI.
Combien de composants contient l'Indice NASDAQ Biotechnology Total Retu ?
L'Indice NASDAQ Biotechnology Total Retu contient 190 composants.
À quel pays appartient l'Indice NASDAQ Biotechnology Total Retu ?
L'Indice NASDAQ Biotechnology Total Retu fait référence à United States.
À quelle bourse appartient l'Indice NASDAQ Biotechnology Total Retu ?
L'Indice NASDAQ Biotechnology Total Retu fait référence à la bourse Nasdaq GIDS.
NASDAQ Biotechnology Total Retu COMPOSANTS
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Amgen AMGN | $296.85 — |
+2.18
|
$159.62B — | $2.27M — | $289.5 — | $297.91 — | $159.62B — | 27.03 | $10.98 — |
| Gilead Sciences GILD | $111.51 — |
-0.2
|
$138.71B — | $5.99M — | $111.09 — | $112.83 — | $138.71B — | 23.42 | $4.76 — |
| Vertex Pharmaceuticals Incorporated VRTX | $457.03 — |
+1.08
|
$117.36B — | $977.78K — | $448 — | $457.75 — | $117.36B — | 0 | -$3.84 — |
| Regeneron Pharmaceuticals REGN | $547.74 — |
+2.4
|
$59.14B — | $817.48K — | $529.69 — | $551.5 — | $59.14B — | 13.92 | $39.33 — |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — |
| Alnylam Pharmaceuticals ALNY | $329.77 — |
+2.39
|
$43B — | $935.42K — | $319.4 — | $330 — | $43B — | 0 | -$2.11 — |
| Biogen BIIB | $133.19 — |
+2.4
|
$19.52B — | $1.47M — | $129.89 — | $134.63 — | $19.52B — | 13.16 | $10.12 — |
| Insmed Incorporated INSM | $98.24 — |
+0.64
|
$18.66B — | $3.24M — | $96.65 — | $98.38 — | $18.66B — | 0 | -$5.93 — |
| Illumina ILMN | $100.34 — |
+2.23
|
$15.88B — | $2.16M — | $97.93 — | $100.96 — | $15.88B — | 0 | -$6.08 — |
| United Therapeutics UTHR | $295.22 — |
+1.48
|
$13.32B — | $383.4K — | $290.08 — | $295.98 — | $13.32B — | 11.76 | $25.09 — |
| Incyte INCY | $68.17 — |
-0.81
|
$13.2B — | $2.28M — | $68 — | $69.1 — | $13.2B — | 340.84 | $0.2 — |
| Neurocrine Biosciences NBIX | $129.4 — |
+1.09
|
$12.81B — | $1.17M — | $127.52 — | $130.41 — | $12.81B — | 43.86 | $2.95 — |
| Exelixis EXEL | $44.3 — |
+1.56
|
$12.08B — | $2.72M — | $43.45 — | $44.43 — | $12.08B — | 20.22 | $2.19 — |
| BioMarin Pharmaceutical BMRN | $57.17 — |
+1.74
|
$10.96B — | $2.95M — | $56.19 — | $57.61 — | $10.96B — | 21.17 | $2.7 — |
| Qiagen QGEN | $48.64 — |
+1.42
|
$10.53B — | $1.19M — | $47.65 — | $48.64 — | $10.53B — | 113.11 | $0.43 — |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — |
| Bio-Techne TECH | $53.18 — |
+2.11
|
$8.34B — | $1.77M — | $51.56 — | $53.23 — | $8.34B — | 64.07 | $0.83 — |
| Blueprint Medicines BPMC | $128.2 — |
-0.11
|
$8.29B — | $2.05M — | $128.2 — | $128.45 — | $8.29B — | 0 | -$2.51 — |
| Grifols, S.A. GRFS | $9.14 — |
+1.56
|
$7.66B — | $222.3K — | $8.99 — | $9.18 — | $7.66B — | 33.85 | $0.27 — |
| Repligen RGEN | $126.96 — |
+0.41
|
$7.13B — | $512.64K — | $125.63 — | $128.19 — | $7.13B — | 0 | -$0.42 — |
- {{ link.label }} {{link}}